Home › Companies › Neurocrine Biosciences, Inc.
How asset managers voted at Neurocrine Biosciences, Inc.’s shareholder meetings, one page per proxy season, compiled from the votes funds and managers report on SEC Form N-PX and the company’s own results on Form 8-K.
| Season | Filed as | Ballot items | Asset managers |
|---|---|---|---|
| 2025-2026 | Neurocrine Biosciences, Inc. | 6 | 632 |
| 2024-2025 | Neurocrine Biosciences, Inc. | 9 | 570 |
| 2023-2024 | NEUROCRINE BIOSCIENCES INC. | 7 | 560 |
Earlier seasons list this company under the name NEUROCRINE BIOSCIENCES INC., as its holders filed it.
Explore Neurocrine Biosciences, Inc. in the interactive database
The seasons are grouped by the issuer number in the company’s CUSIP, not by its name. Ticker as listed by the SEC on October 13, 2026. This page is rebuilt weekly; built October 14, 2026.